|
St. Paul Drug Startup Being Acquired for $100 Million in Cash
Mallinckrodt, the pharmaceuticals business of publicly held Covidien of Ireland, will pay $100 million in cash for St. Paul-based CNS Therapeutics, a five-year-old specialty pharmaceutical company.
Minneapolis Star Tribune |
Register Now
Archives